Ethema Health Corp (GRST)

[Bubae]

No agenda, I made good money on a couple of flips in early 2021 before giving it all back and a little more when I dumped in Q3 2021. The company dumped nearly one billion shares in Q3 and Q4 2021. Then I started digging into the false narrative and history to find that these people are rather above average for the typical OTC sheister. So revealing the misinformation in the press releases using the filings and press release history is considered a attempt to destroy the company. Content which was created by the company itself, so I believe that you give way too much credit to the messenger. What do you call those who have promoted this ticker for years and continue to do so despite what has become so obvious.

Ever see a CEO promote the massive dilution of a regulation "A" offering for more than a year. Think that helps the stock price? The shares of a regulation "A" offering are immediately tradable by those who subscribe and most who trade these markets know it. Much the same as handing over shares to a toxic lender at a discount for debt conversions. The offering is priced at .0012 and you can believe that those who buy into the offering will be doing so at a serious discount to market. We all know how they get there.

This is has become an investment for those who have been averaging down and holding for years. Some hold so many shares that they aren't able to liquidate easily with so little volume. The number of holders of the common is in the neighborhood of 157 if what is stated in the annual filing released in March is to be believed. If this is true then most bag holders here have become resigned to their fate in my opinion. The game now is to flip the news for a couple of ticks as long as hapless traders show up for the promotion.

Pick your odds but do not analyse GRST as if it was an INVESTMENT.

For the fiscal year ended: December 31, 2022
https://www.otcmarkets.com/filing/html?id=16535244&guid=zr5-kesITd8GB3h

PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities .

The last reported sale price of our common stock on the OTC Pink on March 30, 2023 was $0.0004 per share. As of March 30, 2023, there were approximately 157 holders of record of our common stock.